摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,6-bis(methoxymethoxy)-2-{2-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]ethyl}-3-ethylphenyl 4-pyridyl ketone | 819813-02-0

中文名称
——
中文别名
——
英文名称
4,6-bis(methoxymethoxy)-2-{2-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]ethyl}-3-ethylphenyl 4-pyridyl ketone
英文别名
[2-[2-[(2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy]ethyl]-3-ethyl-4,6-bis(methoxymethoxy)phenyl]-pyridin-4-ylmethanone
4,6-bis(methoxymethoxy)-2-{2-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]ethyl}-3-ethylphenyl 4-pyridyl ketone化学式
CAS
819813-02-0
化学式
C26H35NO8
mdl
——
分子量
489.566
InChiKey
NISLEPUXBYBBQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    35
  • 可旋转键数:
    14
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    94.6
  • 氢给体数:
    0
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    4-吡啶甲醛正丁基锂氯化铵2-碘酰基苯甲酸 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 2.5h, 以74%的产率得到4,6-bis(methoxymethoxy)-2-{2-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]ethyl}-3-ethylphenyl 4-pyridyl ketone
    参考文献:
    名称:
    HSP90 FAMILY PROTEIN INHIBITORS
    摘要:
    公开号:
    EP1642880B1
点击查看最新优质反应信息

文献信息

  • Hsp90 FAMILY PROTEIN INHIBITORS
    申请人:Nara Shinji
    公开号:US20090247522A1
    公开(公告)日:2009-10-01
    The present invention provides Hsp90 family protein inhibitors comprising, as an active ingredient, a benzoyl compound represented by general formula (I): (wherein n represents an integer of 0 to 10; R 1 represents substituted or unsubstituted lower alkoxy, substituted or unsubstituted lower alkoxycarbonyl, CONR 7 R 8 or the like; R 2 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group or the like; R 3 and R 5 , which may be the same or different, each represent a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkenyl or the like; and R 4 and R 6 , which may be the same or different, each represent a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like) or a prodrug thereof, or a pharmaceutically acceptable salt of said benzoyl compound or said prodrug.
    本发明提供了Hsp90家族蛋白抑制剂,其包含作为活性成分的苯甲酰化合物,其通式表示为(I):(其中n表示0到10的整数;R1表示取代或未取代的低烷氧基,取代或未取代的低烷氧羰基,CONR7R8或类似物;R2表示取代或未取代的芳基,取代或未取代的芳香杂环基或类似物;R3和R5,可以相同也可以不同,分别表示氢原子,取代或未取代的低烷基,取代或未取代的低烯基或类似物;R4和R6,可以相同也可以不同,分别表示氢原子,卤素,取代或未取代的低烷基,取代或未取代的芳基或类似物)或其前药,或其药学上可接受的盐。
  • Hsp90 family protein inhibitors
    申请人:Nara Shinji
    公开号:US20070032532A1
    公开(公告)日:2007-02-08
    The present invention provides Hsp90 family protein inhibitors comprising, as an active ingredient, a benzoyl compound represented by general formula (I): (wherein n represents an integer of 0 to 10; R 1 represents substituted or unsubstituted lower alkoxy, substituted or unsubstituted lower alkoxycarbonyl, CONR 7 R 8 or the like; R 2 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group or the like; R 3 and R 5 , which may be the same or different, each represent a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkenyl or the like; and R 4 and R 6 , which may be the same or different, each represent a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like) or a prodrug thereof, or a pharmaceutically acceptable salt of said benzoyl compound or said prodrug.
    本发明提供了Hsp90家族蛋白抑制剂,其作为活性成分包括由通式(I)表示的苯甲酰化合物: (其中,n代表0至10的整数;R1代表取代或未取代的较低烷氧基、取代或未取代的较低烷氧羰基、CONR7R8等;R2代表取代或未取代的芳基、取代或未取代的芳香族杂环基等;R3和R5,可以相同也可以不同,每个代表氢原子、取代或未取代的较低烷基、取代或未取代的较低烯基等;R4和R6,可以相同也可以不同,每个代表氢原子、卤素、取代或未取代的较低烷基、取代或未取代的芳基等)或其前药,或所述苯甲酰化合物或其前药的药学上可接受的盐。
  • US7538224B2
    申请人:——
    公开号:US7538224B2
    公开(公告)日:2009-05-26
  • US7767693B2
    申请人:——
    公开号:US7767693B2
    公开(公告)日:2010-08-03
  • HSP90 FAMILY PROTEIN INHIBITORS
    申请人:Kyowa Hakko Kirin Co., Ltd.
    公开号:EP1642880B1
    公开(公告)日:2013-09-04
查看更多